| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 596.499 | 93 |
| GSM780708 | Untreated after 4 days (C2_1) | 522.419 | 92 |
| GSM780709 | Untreated after 4 days (C3_1) | 461.454 | 91 |
| GSM780719 | Untreated after 4 days (C1_2) | 571.607 | 92 |
| GSM780720 | Untreated after 4 days (C2_2) | 601.344 | 93 |
| GSM780721 | Untreated after 4 days (C3_2) | 492.481 | 91 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 512.946 | 92 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 701.985 | 94 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 620.477 | 93 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 485.586 | 91 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 681.763 | 94 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 637.427 | 93 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 672.639 | 93 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 581.469 | 93 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 642.436 | 93 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 677.872 | 94 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 567.061 | 92 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 669.483 | 93 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 914.601 | 95 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 820.214 | 95 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 625.25 | 93 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 889.065 | 95 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 658.284 | 93 |